Key result
DWORF expression was significantly reduced in both cardiac and skeletal muscle of DMD-affected dogs aged 8 months or older.
Why the study?
Existing murine anti-DWORF antibodies are ineffective in canines, leaving DWORF expression uninvestigated in the canine DMD translational model.
The development of a canine-specific anti-DWORF antibody revealed reduced DWORF expression in a canine DMD model, establishing a foundation for evaluating DWORF-based gene therapy for DMD cardiomyopathy.
Hypothesis-generating for DWORF gene therapy in DMD cardiomyopathy; human translation remains untested.
Duchenne muscular dystrophy (DMD) is a lethal muscle-wasting disease driven by cytosolic calcium overload, which leads to muscle degeneration. Sarco/endoplasmic reticulum calcium ATPase (SERCA), a key regulator of cytosolic calcium levels, exhibits reduced activity in animal models of DMD and human patients. Dwarf open reading frame (DWORF), a positive SERCA regulator, is downregulated in mdx DMD mice, and adeno-associated virus-mediated DWORF overexpression has been shown to ameliorate DMD cardiomyopathy. The canine DMD model provides a crucial bridge for translating findings from mice to humans. To investigate DWORF expression in this model, we developed a canine-specific anti-DWORF antibody, as the existing murine antibody is ineffective. This antibody detected DWORF in human, pig, cat and rabbit muscle, but not in mouse muscle. DWORF was absent in muscle tissues of neonatal normal dogs but highly expressed in those of adult dogs. In DMD-affected dogs aged 8 months or older, DWORF expression was significantly reduced in both cardiac and skeletal muscle. This study establishes a foundation for evaluating DWORF-based gene therapy in the canine DMD model, advancing the potential for clinical translation.
No takes yet. Share an insight, caveat, or question.
Gibson et al. (2025) studied Duchenne muscular dystrophy. Duchenne muscular dystrophy vs. Normal dogs was evaluated on DWORF expression in cardiac and skeletal muscle. DWORF expression was significantly reduced in both cardiac and skeletal muscle of DMD-affected dogs aged 8 months or older.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: